Department of Urology, School of Health Sciences, Faculty of Medicine, University of Thessaly, University Hospital of Larissa, 41110 Larissa, Greece.
Department of Vascular Surgery, School of Health Sciences, Faculty of Medicine, University of Thessaly, University Hospital of Larissa, 41110 Larissa, Greece.
Curr Oncol. 2023 Jun 4;30(6):5448-5455. doi: 10.3390/curroncol30060412.
Testicular germ cell tumors (TGCTs) are the leading cause of cancer-related death in males between the ages of 20 and 40. In the advanced stages, the combination of cisplatin-based chemotherapy and surgical excision of the remaining tumor can cure many of these patients. Vascular procedures may be required during retroperitoneal lymph node dissection (RPLND) in order to achieve the complete excision of all residual retroperitoneal masses. Careful assessment of pre-operative imaging and the identification of patients who could benefit from additional procedures are important for minimizing peri- and postoperative complications. We report on a case of a 27-year-old patient with non-seminomatous TGCT, who successfully underwent post-chemotherapy RPLND with additional infrarenal inferior vena cava (IVC) and complete abdominal aorta replacement using synthetic grafts.
睾丸生殖细胞肿瘤 (TGCTs) 是 20 至 40 岁男性癌症相关死亡的主要原因。在晚期，顺铂为基础的化疗与剩余肿瘤的手术切除相结合，可以治愈许多此类患者。在腹膜后淋巴结清扫术 (RPLND) 过程中，可能需要血管手术，以实现所有残余腹膜后肿块的完全切除。仔细评估术前影像学检查，并确定哪些患者可能受益于额外的手术，对于减少围手术期并发症非常重要。我们报告了一例 27 岁非精原细胞瘤 TGCT 患者的病例，该患者成功接受了化疗后 RPLND 手术，术中使用合成移植物额外进行了肾下下腔静脉 (IVC) 和整个腹主动脉置换。
